Cannabis Poland S.A. (WSE: CBD)
Health Care · Pharmaceuticals · PL
zł0.23
+4.59% today · -19.0% 1Y
Cannabis Poland S.A. (WSE: CBD) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.14M.
Over the last twelve months the share price has lost 19.0%, trading between 0.14 and 0.31.
Tweenvest scores Cannabis Poland S.A. across four factors: quality 36/100, value 33/100, growth 0/100. Its strongest factor is quality.
CBD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.14M
- Revenue (TTM)
- $54.73K
- P/E
- —
- EPS
- -0.04
- Dividend yield
- —
- Beta (5Y)
- 0.36
- 52-week high
- zł0.31
- 52-week low
- zł0.14
- Avg volume (3M)
- —
- Shares outstanding
- 74.36M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| cbdMD, Inc.NYSEAM: YCBD | $4.37M | $0.37 | -5.10% |
| Nuformix plcLSE: NFX | $4.32M | £0.00 | -4.00% |
| Futura Medical plcAIM: FUM | $4.32M | £0.00 | 0.00% |
| Zelira Therapeutics LimitedASX: ZLD | $4.24M | AU$— | — |
| Instituto Rosenbusch S.A.BASE: ROSE | $4.07M | AR$145.00 | +3.20% |
| CordovaCann Corp.OTCPK: LVRL.F | $3.84M | $0.04 | +75.00% |
| PharmaTher Holdings Ltd.CNSX: PHRM | $3.83M | CA$0.06 | +9.09% |
| Vista Pharmaceuticals LimitedBSE: 524711 | $3.82M | Rs6.00 | -3.38% |
Figures last refreshed Oct 11, 2026.